elotuzumab (Empliciti)

From Aaushi
Jump to navigation Jump to search

Indications

Dosage

400 MG Injection [Empliciti]

Adverse effects

Mechanism of action

More general terms

References

  1. 1.0 1.1 1.2 Lonial S, Dimopoulos M, Palumbo A et al Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma. N Engl J Med. 2015 Aug 13;373(7):621-31.. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26035255